Frank Rimerman Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Frank Rimerman Advisors's BIIB Position: Q3 2026 in Review
Frank Rimerman Advisors increased its Biogen (BIIB) stake by 0.37% in Q3 2026, buying an estimated $4.03K and bringing the position to 5,216 shares worth $1.18M. The position accounts for 0.07% of the portfolio, ranked #221.
Frank Rimerman Advisors first reported a position in BIIB in Q4 2023 and has held it in 9 quarters since. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Frank Rimerman Advisors held 5,216 shares of Biogen worth $1.18M as of Q3 2026.
- Frank Rimerman Advisors bought 19 Biogen shares in Q3 2026, an estimated $4.03K.
- Biogen made up 0.07% of Frank Rimerman Advisors's portfolio in Q3 2026, its #221 holding.
- Frank Rimerman Advisors first reported a position in Biogen in Q4 2023 and has held it in 9 quarters since.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.